Related Experiment Videos
Trophoblast membrane infusion for unexplained recurrent miscarriage
P M Johnson1, K V Chia, C A Hart
1Department of Immunology, University of Liverpool, UK.
British Journal of Obstetrics and Gynaecology
|April 1, 1988
Abstract:
A novel protocol is described which has been developed for immunotherapy in unexplained recurrent miscarriage. This is based on a single intravenous infusion with isolated placental trophoblast plasma membrane vesicle preparations. Clinical experience gained with this approach is described. A total of 16/21 (76%) patients who subsequently had pregnancies have now achieved a live birth or are currently pregnant at greater than 28 weeks gestation.